APPLICATION
ANDA212883
TYPE
ANDA
ORIGINAL APPROVAL
2019-11-27
LATEST ACTION
2024-01-03
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Prescription
Products
SILDENAFIL CITRATEPrescription
SILDENAFIL CITRATE EQ 10MG BASE/ML · FOR SUSPENSION · ORAL
Approval history
2024-01-03Labeling · Supplement 11 · standardAP
2021-10-08Labeling · Supplement 3 · standardAP
2019-11-27UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.